BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,059 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $232,233 | +10.5% | 5,397 | 0.0% | 0.05% | +7.0% |
Q4 2023 | $210,213 | +2.4% | 5,397 | 0.0% | 0.04% | -8.5% |
Q3 2023 | $205,248 | -17.1% | 5,397 | 0.0% | 0.05% | -9.6% |
Q2 2023 | $247,452 | -1.6% | 5,397 | -12.3% | 0.05% | -1.9% |
Q1 2023 | $251,391 | -20.4% | 6,154 | -0.1% | 0.05% | -18.5% |
Q4 2022 | $315,744 | +7.8% | 6,160 | +13.9% | 0.06% | -3.0% |
Q3 2022 | $293,000 | -15.6% | 5,408 | +0.6% | 0.07% | -23.0% |
Q2 2022 | $347,000 | -15.8% | 5,377 | +1.5% | 0.09% | -1.1% |
Q1 2022 | $412,000 | -9.6% | 5,300 | 0.0% | 0.09% | +1.1% |
Q4 2021 | $456,000 | +6.5% | 5,300 | 0.0% | 0.09% | -15.5% |
Q3 2021 | $428,000 | 0.0% | 5,300 | 0.0% | 0.10% | -14.9% |
Q2 2021 | $428,000 | -4.5% | 5,300 | 0.0% | 0.12% | -13.6% |
Q1 2021 | $448,000 | +4.9% | 5,300 | 0.0% | 0.14% | +9.4% |
Q4 2020 | $427,000 | -0.2% | 5,300 | 0.0% | 0.13% | -46.4% |
Q3 2020 | $428,000 | -6.6% | 5,300 | 0.0% | 0.24% | -13.4% |
Q2 2020 | $458,000 | +6.3% | 5,300 | 0.0% | 0.28% | -2.5% |
Q1 2020 | $431,000 | -2.9% | 5,300 | 0.0% | 0.28% | +59.0% |
Q4 2019 | $444,000 | -4.9% | 5,300 | -0.4% | 0.18% | -11.9% |
Q3 2019 | $467,000 | +6.9% | 5,323 | 0.0% | 0.20% | -14.8% |
Q2 2019 | $437,000 | +0.7% | 5,323 | 0.0% | 0.24% | +7.7% |
Q1 2019 | $434,000 | +23.6% | 5,323 | 0.0% | 0.22% | +11.1% |
Q4 2018 | $351,000 | -14.6% | 5,323 | 0.0% | 0.20% | +1.0% |
Q3 2018 | $411,000 | +4.3% | 5,323 | 0.0% | 0.20% | 0.0% |
Q2 2018 | $394,000 | -22.7% | 5,323 | -32.0% | 0.20% | -13.7% |
Q1 2018 | $510,000 | +33.5% | 7,823 | +32.7% | 0.23% | +31.2% |
Q4 2017 | $382,000 | – | 5,895 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |